Literature DB >> 19179875

Role of the innate immune system in the pathogenesis of inflammatory bowel disease.

Pieter P E van Lierop1, Janneke N Samsom, Johanna C Escher, Edward E S Nieuwenhuis.   

Abstract

Crohn disease and ulcerative colitis are chronic inflammatory diseases of the intestinal tract commonly denoted as inflammatory bowel diseases. It has been proposed that these diseases result from aberrant mucosal immune responses to nonpathogenic microbial residents of the intestines. Recently, it was established that continuous interactions between the innate and the adaptive intestinal immune cells and the microbiota are directly involved in maintaining the physiological noninflammatory state of the intestinal mucosa. In light of the complexity of this mucosal homeostasis, it is astonishing that the inflammatory bowel diseases are relatively rare. Recently, altered functions of the innate immune system have been identified. As such, both hyperresponsiveness and hyporesponsiveness of innate cells have been implicated in the pathogenesis of inflammatory bowel diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19179875     DOI: 10.1097/MPG.0b013e3181821964

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  17 in total

1.  Pulmonary manifestations in inflammatory bowel disease: a prospective study.

Authors:  Devendra Desai; Samir Patil; Zarir Udwadia; Shailendra Maheshwari; Philip Abraham; Anand Joshi
Journal:  Indian J Gastroenterol       Date:  2011-09-21

Review 2.  Pulmonary manifestations of inflammatory bowel disease.

Authors:  Xiao-Qing Ji; Li-Xia Wang; De-Gan Lu
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

3.  Moxibustion inhibits interleukin-12 and tumor necrosis factor alpha and modulates intestinal flora in rat with ulcerative colitis.

Authors:  Xiao-Mei Wang; Yuan Lu; Lu-Yi Wu; Shu-Guang Yu; Bai-Xiao Zhao; Hong-Yi Hu; Huan-Gan Wu; Chun-Hui Bao; Hui-Rong Liu; Jin-Hai Wang; Yi Yao; Xue-Gui Hua; Hui-Ying Guo; Li-Rong Shen
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

4.  Immune phenotype in children with therapy-naïve remitted and relapsed Crohn's disease.

Authors:  Aron Cseh; Barna Vasarhelyi; Kriszta Molnar; Balazs Szalay; Peter Svec; Andras Treszl; Antal Dezsofi; Peter-Laszlo Lakatos; Andras Arato; Tivadar Tulassay; Gabor Veres
Journal:  World J Gastroenterol       Date:  2010-12-21       Impact factor: 5.742

5.  Protective effects of Kurozu and Kurozu Moromimatsu on dextran sulfate sodium-induced experimental colitis.

Authors:  Toru Shizuma; Kazuo Ishiwata; Masanobu Nagano; Hidezo Mori; Naoto Fukuyama
Journal:  Dig Dis Sci       Date:  2010-10-09       Impact factor: 3.199

6.  Assessment of Occult Pulmonary Involvement in Ulcerative Colitis.

Authors:  Sudhir J Gupta; Vineet L Gupta; Harit G Kothari; Amol R Samarth; Nitin R Gaikwad; Sahil M Parmar
Journal:  Inflamm Intest Dis       Date:  2020-07-01

7.  Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells.

Authors:  Valerio Rossini; Katarina Radulovic; Christian U Riedel; Jan Hendrik Niess
Journal:  J Vis Exp       Date:  2016-09-18       Impact factor: 1.355

8.  Murine neonates infected with Yersinia enterocolitica develop rapid and robust proinflammatory responses in intestinal lymphoid tissues.

Authors:  David T Siefker; Andrea Echeverry; Roberta Brambilla; Masayuki Fukata; Kurt Schesser; Becky Adkins
Journal:  Infect Immun       Date:  2013-12-02       Impact factor: 3.441

9.  Crohn's disease with pulmonary granuloma in a child: a case report and review of the literature.

Authors:  Wei Cao; Xing Deng; Chundi Xu; Xinqiong Wang; Yi Yu; Xu Xu; Jia Li; Yuan Xiao
Journal:  Transl Pediatr       Date:  2021-06

10.  Macrophage migration inhibitory factor polymorphism and the risk of ulcerative colitis and Crohn's disease in Asian and European populations: a meta-analysis.

Authors:  Ning-Bo Hao; Ya Fei He; Gang Luo; Xin Yong; Yao Zhang; Shi-Ming Yang
Journal:  BMJ Open       Date:  2013-12-23       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.